$PRKR
PARKERVISION INC Stock $prkr

$prkr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924008859 Filed on March 21, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$25.00M
YoY Change	-100.0%	-100.0%	2602.7%
Cost Of Revenue	$59.00K	$60.00K	$227.0K
YoY Change	37.21%	2900.0%	2170.0%
Gross Profit	-$59.00K	-$60.00K	$24.77M
YoY Change	-100.24%	-106.5%	2607.43%
Gross Profit Margin			99.09%
Selling, General & Admin	$773.0K	$630.0K	$14.74M
YoY Change	-93.6%	-74.9%	89.68%
% of Gross Profit			59.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$60.00K	$56.00K	$256.0K
YoY Change	-9.09%	-23.29%	-17.68%
% of Gross Profit			1.03%
Operating Expenses	$773.0K	$630.0K	$14.74M
YoY Change	-93.6%	-74.9%	89.68%
Operating Profit	-$832.0K	-$690.0K	$10.03M
YoY Change	-106.46%	-56.52%	-246.24%
Interest Expense	$104.0K	-$75.00K	$424.0K
YoY Change	-1.89%	-1.32%	30.86%
% of Operating Profit			4.23%
Other Income/Expense, Net	$139.0K	-$345.0K	-$514.0K
YoY Change	-42.8%	-90.63%	-82.61%
Pretax Income	-$693.0K	-$1.110M	$9.515M
YoY Change	-105.28%	-79.23%	-196.96%
Income Tax	$0.00		$0.00
% Of Pretax Income			0.0%
Net Earnings	-$693.0K	-$1.110M	$9.515M
YoY Change	-105.28%	-79.23%	-197.09%
Net Earnings / Revenue			38.06%
Basic Earnings Per Share	-$0.01		$0.11
Diluted Earnings Per Share	-$0.01	-$0.01	$0.08
COMMON SHARES
Basic Shares Outstanding	88.30M	87.51M	85.73M
Diluted Shares Outstanding	88.16M		119.9M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.734M	$2.560M	$2.560M
YoY Change	1184.44%	2248.62%	2248.62%
Cash & Equivalents	$1.700M	$2.600M	$2.560M
Short-Term Investments
Other Short-Term Assets	$36.00K	$34.00K	$95.00K
YoY Change	50.0%	13.33%	-65.33%
Inventory
Prepaid Expenses	$60.00K	$61.00K
Receivables
Other Receivables
Total Short-Term Assets	$1.830M	$2.655M	$2.655M
YoY Change	-87.21%	593.21%	593.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$996.0K	$1.055M
YoY Change	-20.45%	-22.37%
Long-Term Investments
YoY Change
Other Assets	$312.0K	$313.0K	$313.0K
YoY Change	7700.0%	6160.0%	6160.0%
Total Long-Term Assets	$1.308M	$1.368M	$1.368M
YoY Change	3.89%	0.0%	0.0%
TOTAL ASSETS
Total Short-Term Assets	$1.830M	$2.655M	$2.655M
Total Long-Term Assets	$1.308M	$1.368M	$1.368M
Total Assets	$3.138M	$4.023M	$4.023M
YoY Change	-79.84%	129.75%	129.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$427.0K	$573.0K	$573.0K
YoY Change	-47.28%	-36.4%	-36.4%
Accrued Expenses	$555.0K	$537.0K	$162.0K
YoY Change	-4.31%	-9.29%	-2.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.555M	$1.179M	$1.179M
YoY Change	3.32%	54.32%	54.32%
Total Short-Term Liabilities	$2.537M	$2.289M	$2.289M
YoY Change	-12.37%	1.42%	1.42%
LONG-TERM LIABILITIES
Long-Term Debt	$40.62M	$41.25M	$41.25M
YoY Change	281.52%	335.39%	335.39%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$40.62M	$41.25M	$41.25M
YoY Change	-18.02%	-17.79%	-17.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.537M	$2.289M	$2.289M
Total Long-Term Liabilities	$40.62M	$41.25M	$41.25M
Total Liabilities	$43.16M	$43.54M	$43.54M
YoY Change	-17.7%	-16.97%	-16.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$434.4M	-$433.7M
YoY Change	1.0%	-2.14%
Common Stock	$884.0K	$877.0K
YoY Change	4.62%	8.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$40.02M	-$39.52M	-$39.52M
YoY Change
Total Liabilities & Shareholders Equity	$3.138M	$4.023M	$4.023M
YoY Change	-79.84%	129.75%	129.75%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$693.0K	-$1.110M	$9.515M
YoY Change	-105.28%	-79.23%	-197.09%
Depreciation, Depletion And Amortization	$60.00K	$56.00K	$256.0K
YoY Change	-9.09%	-23.29%	-17.68%
Cash From Operating Activities	-$800.0K	-$739.0K	$10.80M
YoY Change	-106.06%	22.55%	-460.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$2.000K	$2.000K
YoY Change			-50.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$2.000K	-$2.000K
YoY Change			-50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$33.00K	-28.00K	-$8.338M
YoY Change	-104.14%	-107.39%	-508.33%
NET CHANGE
Cash From Operating Activities	-$800.0K	-739.0K	$10.80M
Cash From Investing Activities	$0.00	-2.000K	-$2.000K
Cash From Financing Activities	-$33.00K	-28.00K	-$8.338M
Net Change In Cash	-$826.0K	-769.0K	$2.451M
YoY Change	-105.92%	243.3%	-366.12%
FREE CASH FLOW
Cash From Operating Activities	-$800.0K	-$739.0K	$10.80M
Capital Expenditures	$0.00	$2.000K	$2.000K
Free Cash Flow	-$800.0K	-$741.0K	$10.80M
YoY Change	-106.06%	22.89%	-459.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87681000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87681000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81246000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81246000
CY2023Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	0	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10300000
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-22904
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-2971472
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4446-1A Hendricks Avenue, Suite 354
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Jacksonville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32207
CY2023	dei	City Area Code CityAreaCode	904
CY2023	dei	Local Phone Number LocalPhoneNumber	732-6100
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	7864384	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88295803
CY2023	dei	Auditor Firm AuditorFirmId	569
CY2023	dei	Auditor Name AuditorName	MSL, P.A.
CY2023	dei	Auditor Location AuditorLocation	Fort Lauderdale, Florida
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2560000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	61000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2655000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	383000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1055000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1359000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	313000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9000	usd
CY2023Q4	us-gaap	Assets Assets	4023000	usd
CY2022Q4	us-gaap	Assets Assets	1751000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	573000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	67000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	447000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	490000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1045000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	625000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	134000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	139000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2289000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2257000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	29402000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	40708000	usd
CY2023Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	7618000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	5089000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3893000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3913000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	340000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	473000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	41253000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	50183000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	43542000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52440000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	877000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	812000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	393314000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	391724000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-433710000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-443225000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-39519000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4023000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1751000	usd
CY2023	us-gaap	Revenues Revenues	25000000	usd
CY2022	us-gaap	Revenues Revenues	925000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	227000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10000	usd
CY2023	us-gaap	Gross Profit GrossProfit	24773000	usd
CY2022	us-gaap	Gross Profit GrossProfit	915000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14744000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7773000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14744000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7773000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	58000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	103000	usd
CY2023	us-gaap	Interest Expense InterestExpense	424000	usd
CY2022	us-gaap	Interest Expense InterestExpense	324000	usd
CY2023	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-148000	usd
CY2022	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-2734000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-514000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2955000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9515000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9813000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9515000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9813000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9515000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9813000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85732000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78395000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119888000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78395000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-44777000	usd
CY2022	prkr	Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net IssuanceOfCommonStockUponExerciseOfOptionsAndWarrantsPrivateNet	382000	usd
CY2022	prkr	Issuance Of Common Stock Upon Exercise Of Options And Warrants IssuanceOfCommonStockUponExerciseOfOptionsAndWarrants	83000	usd
CY2022	prkr	Issuance Of Common Stock And Warrants For Services Value IssuanceOfCommonStockAndWarrantsForServicesValue	59000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3081000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9813000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2023	prkr	Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net IssuanceOfCommonStockUponExerciseOfOptionsAndWarrantsPrivateNet	430000	usd
CY2023	prkr	Issuance Of Common Stock Upon Exercise Of Options And Warrants IssuanceOfCommonStockUponExerciseOfOptionsAndWarrants	4000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	127000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	503000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9515000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-39519000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9515000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9813000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	256000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	311000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	503000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3081000	usd
CY2023	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-148000	usd
CY2022	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-2734000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-55000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-124000	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	402000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	299000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-306000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-396000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-394000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-91000	usd
CY2023	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	1276000	usd
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	6854000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10791000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2959000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4000	usd
CY2023	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	121000	usd
CY2022	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	382000	usd
CY2023	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	4000	usd
CY2022	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	83000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8338000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2042000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2451000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-921000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	109000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1030000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2560000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	109000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	24000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	24000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Use of Estimates in the Preparation of Financial Statements </b></p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The more significant estimates made by us include projected future cash flows and risk-adjusted discount rates for estimating the fair value of our contingent payment obligations, the volatility and estimated lives of share-based awards used in the estimate of the fair market value of share-based compensation, the assessment of recoverability of long-lived assets, the amortization periods for intangible and long-lived assets, and the valuation allowance for deferred taxes. Actual results could differ from the estimates made. We periodically evaluate estimates used in the preparation of the financial statements for continued reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation.</p>
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119888000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78395000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2600000	usd
CY2023Q4	prkr	Net Working Capital NetWorkingCapital	400000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-433700000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10800000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	100000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	200000	usd
CY2023	prkr	Proceeds From Issuance Of Debt And Equity ProceedsFromIssuanceOfDebtAndEquity	900000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	25000000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	930000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9515000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9813000	usd
CY2023	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	402000	usd
CY2022	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	0	usd
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	9917000	usd
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-9813000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85732000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78395000
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	34156000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36380000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	67460000
CY2023Q4	prkr	Prepaid Services PrepaidServices	31000	usd
CY2022Q4	prkr	Prepaid Services PrepaidServices	202000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	12000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	25000	usd
CY2023Q4	prkr	Prepaid Licenses Software Tools And Support PrepaidLicensesSoftwareToolsAndSupport	16000	usd
CY2022Q4	prkr	Prepaid Licenses Software Tools And Support PrepaidLicensesSoftwareToolsAndSupport	15000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	61000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10431000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14319000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9376000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12960000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1055000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1359000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	250000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-60000.00	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-120000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	228000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	193000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	132000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	115000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	99000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	288000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1055000	usd
CY2023Q4	prkr	Accrued Advances Current And Noncurrent AccruedAdvancesCurrentAndNoncurrent	375000	usd
CY2022Q4	prkr	Accrued Advances Current And Noncurrent AccruedAdvancesCurrentAndNoncurrent	425000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	66000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	56000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	6000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	9000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	447000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	490000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	134000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	139000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	144000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	57000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	474000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	4938000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	4538000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1045000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	625000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3893000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3913000	usd
CY2023	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"><em style="font: inherit;">10.</em> <span style="text-decoration: underline; ">CONTINGENT PAYMENT OBLIGATIONS</span></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Secured Contingent Payment Obligation</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The following table provides a reconciliation of our secured contingent payment obligation measured at estimated fair market value for the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em>, respectively (in thousands):</p> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 11pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td style="font-family: Times New Roman; font-size: 11pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><em style="font: inherit;">2023</em></p> </td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 11pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><em style="font: inherit;">2022</em></p> </td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; width: 70%;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Secured contingent payment obligation, beginning of year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">40,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">37,372</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 11pt; font-family: Times New Roman;">Proceeds from contingent payment obligation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">5,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 11pt; font-family: Times New Roman;">Repayment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">(13,925</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Change in fair value</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,381</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,336</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Secured contingent payment obligation, end of year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">29,402</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">40,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td></tr> </tbody></table> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">Our secured contingent payment obligation represents the estimated fair value of our repayment obligation to Brickell Key Investments, LP (“Brickell”) under a <em style="font: inherit;"> February 2016 </em>funding agreement, as amended from time to time. On <em style="font: inherit;"> August 14, 2023, </em>the contingent funding agreement with Brickell was replaced with a secured, non-recourse note (the "Note") and a prepaid forward purchase agreement (the "PPFPA"). The Note has a face value of $45.5 million ("Face Value"), accrues simple interest at a fixed rate, and matures on <em style="font: inherit;"> August 14, 2028. </em>Payments under the Note will be made solely from proceeds from our patent assets, net of contingent fees payable to attorneys ("Distributions"). We are obligated to pay <em style="font: inherit;">one hundred</em> percent (100%) of the <em style="font: inherit;">first</em> $5.8 million in Distributions to Brickell, and thereafter will pay a percentage of Distributions, which varies depending upon the origin of the Distributions, until the Face Value of the Note, and accrued interest thereon, has been repaid in full. If the amounts payable to Brickell from Distributions are insufficient to repay the face value and interest accrued on the Note by the maturity date, our remaining repayment obligations under the Note will be reduced to <em style="font: inherit;">zero</em> with future payment obligations, if any, being determined under the PPFPA. The Note is secured by our patent assets and related proceeds and contains standard and customary representations, warranties and covenants. The Note contains events of default including, but <em style="font: inherit;">not</em> limited to, (a) failure to pay principal or interest on the Note when due; (b) breach of representations or covenants, (c) impairment in the perfection or priority of Brickell's security interests in the collateral, and (d) bankruptcy or dissolution of the Company. In the event of a default, the outstanding principal and accrued interest on the Note will become immediately due and payable. The PPFPA extends beyond the maturity date of the Note and provides that Brickell is entitled to a specified percentage of monetary recoveries resulting from our patent-related actions to the extent <em style="font: inherit;">not</em> already paid to Brickell under the Note, or otherwise prior to the inception of the Note. The PPFPA also contains standard and customary representations, warranties and covenants. The Note and PPFPA are collectively referred to as our secured contingent payment obligation.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">To date, we have received aggregate proceeds of $23 million in exchange for Brickell’s right to reimbursement and compensation from gross proceeds resulting from patent enforcement and other patent monetization actions and have repaid an aggregate of $17.3 million from patent license and settlement proceeds. The underlying carrying value of the Note, which includes the Face Value plus accrued interest, was approximately $51.0 million as of <em style="font: inherit;"> December 31, 2023, </em>which compares to the minimum return due to Brickell under the prior agreement of $56.9 million as of <em style="font: inherit;"> December 31, 2022. </em>The range of potential proceeds payable to Brickell is discussed more fully in Note <em style="font: inherit;">11.</em> </p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">Brickell holds a senior security interest in the majority of our assets until such time as the Note, including accrued interest thereon, is paid in full. The security interest is enforceable by Brickell in the event that we are in default under the agreement which would occur if (i) we fail, after notice, to pay proceeds to Brickell, (ii) we become insolvent or insolvency proceedings are commenced (and <em style="font: inherit;">not</em> subsequently discharged) with respect to us, (iii) our creditors commence actions against us (which are <em style="font: inherit;">not</em> subsequently discharged) that affect our material assets, (iv) we, without Brickell’s consent, incur indebtedness other than immaterial ordinary course indebtedness, or (v) there is an uncured non-compliance of our obligations or misrepresentations under the agreement. As of <em style="font: inherit;"> December 31, 2023</em>, we are in compliance with our obligations under this agreement.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">We have elected to measure our secured contingent payment obligation at its estimated fair value based on probability-weighted estimated cash outflows, discounted back to present value using a discount rate determined in accordance with accepted valuation methods (see Note <em style="font: inherit;">11</em>). The secured contingent payment obligation is remeasured to fair value at each reporting period with changes recorded in the consolidated statements of comprehensive income (loss) until the contingency is resolved.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Unsecured Contingent Payment Obligations</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The following table provides a reconciliation of our unsecured contingent payment obligations, measured at estimated fair market value, for the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em>, respectively (in thousands):</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 11pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><em style="font: inherit;">2023</em></p> </td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><em style="font: inherit;">2022</em></p> </td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; width: 70%;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Unsecured contingent payment obligations, beginning of year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">5,089</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">5,691</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Change in fair value</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,529</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(602</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Unsecured contingent payment obligations, end of year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7,618</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,089</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td></tr> </tbody></table> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">Our unsecured contingent payment obligations represent amounts payable to others from future patent-related proceeds including (i) a termination fee due to a litigation funder (“Termination Fee”) and (ii) contingent payment rights (“CPRs”) issued to accredited investors primarily in connection with equity financings. We have elected to measure these unsecured contingent payment obligations at their estimated fair value based on probability-weighted estimated cash outflows, discounted back to present value using a discount rate determined in accordance with accepted valuation methods. The unsecured contingent payment obligations will be remeasured to fair value at each reporting period with changes recorded in the consolidated statements of comprehensive income (loss) until the contingency is resolved (see Note <em style="font: inherit;">11</em>).</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The Termination Fee is a result of $1.0 million in advances received under a letter agreement with a <em style="font: inherit;">third</em>-party funder. Based on the terms of the letter agreement, if a final funding arrangement was <em style="font: inherit;">not</em> executed by <em style="font: inherit;"> March 31, 2020, </em>we would be obligated to pay, from future patent-related proceeds, an aggregate termination payment equal to <em style="font: inherit;">five</em> times the advances received, or approximately $5.0 million. We did <em style="font: inherit;">not</em> consummate a funding agreement and accordingly the advances were recorded as an unsecured contingent payment obligation at <em style="font: inherit;"> March 31, 2020, </em>when the Termination Fee obligation was incurred. As of <em style="font: inherit;"> December 31, 2023</em>, the estimated fair value of unsecured contingent payment obligations related to the Termination Fee is $3.5 million.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The CPRs represent the estimated fair value of rights provided to accredited investors who purchased shares of our common stock in <em style="font: inherit;">2020</em> and <em style="font: inherit;">2021</em> and the fair value of a right issued to a <em style="font: inherit;">third</em>-party in connection with a service agreement during the year ended <em style="font: inherit;"> December 31, 2020. </em>No sales of common stock with contingent payment rights were completed during the years ended <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em>. The terms of the CPRs provide that we will pay each investor an allocated portion of our net proceeds from patent-related actions, after taking into account fees and expenses payable to law firms representing us and amounts payable to Brickell. The investors’ allocated portion of net proceeds will be determined by multiplying the net proceeds recovered by us (up to $10 million) by the quotient of such investors’ subscription amount divided by $10 million, up to an amount equal to each investor’s subscription amount, or an aggregate of $5.8 million. As of <em style="font: inherit;"> December 31, 2023</em>, the estimated fair value of our unsecured contingent payment obligations related to the CPRs is $4.1 million.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p>
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1998000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2061000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	409000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-422000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2512000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2416000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	105000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	67000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	70159000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	75470000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4565000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5356000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1350000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1127000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	568000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1482000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	7071000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	7033000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	2000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	1000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	83714000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	90467000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83714000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	90467000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	279800000	usd
CY2023Q4	prkr	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	239100000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	638000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	15000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	638000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	638000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2023Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	300000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10300000
CY2023	prkr	Class Of Warrant Or Right Weighted Average Remaining Life ClassOfWarrantOrRightWeightedAverageRemainingLife	P1Y6M
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	500000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3100000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	150000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	25834000
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.4
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y6M
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	24659000
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.4
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y4M24D

Files In Submission

Name	View Source	Status
0001437749-24-008859-index-headers.html	Edgar Link	pending
0001437749-24-008859-index.html	Edgar Link	pending
0001437749-24-008859.txt	Edgar Link	pending
0001437749-24-008859-xbrl.zip	Edgar Link	pending
ex_599095.htm	Edgar Link	pending
ex_599096.htm	Edgar Link	pending
ex_599097.htm	Edgar Link	pending
ex_599098.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mslcpa.jpg	Edgar Link	pending
prkr-20231231.xsd	Edgar Link	pending
prkr20231231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
prkr-20231231_cal.xml	Edgar Link	unprocessable
prkr-20231231_def.xml	Edgar Link	unprocessable
prkr-20231231_lab.xml	Edgar Link	unprocessable
prkr-20231231_pre.xml	Edgar Link	unprocessable
prkr20231231_10k_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRKR
PARKERVISION INC Stock $prkr

2024 Q1 Form 10-K Financial Statement

#000143774924008859 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR PARKERVISION INC Stock $prkr

2024 Q1 Form 10-K Financial Statement

#000143774924008859 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR
PARKERVISION INC Stock $prkr